News

The bactericidal, once-daily injectable lipoglycopeptide antibacterial agent is indicated for nosocomial pneumonia, including ventilator-associated pneumonia, believed to be caused by methicillin resistant Staphylococcus aureus when no other alternatives

The termination of the collaboration that was signed in 2009 is effective 3 September 2013. Astellas president and CEO Yoshihiko Hatanaka said, "While our decision is based on

The two-year award worth $900,000 is entitled, ‘EMR/EDC HUB – An Electronic Bridge between Medicine and Science’. Target Health President Dr. Jules Mitchel said, "With over 20 years

The acquired portfolio of cyclophilin inhibitors belongs to Sangamides, a new class of molecules. Sangamides leverage novel chemistry platform of polyketides and are believed to form basis for

Catalent has agreed to acquire a major stake in privately owned Zhejiang Jiang Yuan Tang Biotechnology, which manufactures nutritional softgel products for Chinese and Asia Pacific markets. The

The latest version will enable CROs and sponsors to self-configure a study workspace in short time using One Click Configuration wizard. ePharma CEO Lance Converse said that configuring

The drug, which is in mid-stage clinical testing, is facing competition from new hepatitis C treatments developed by Gilead Sciences (GILD) and AbbVie (ABBV). Pfizer spokeswoman Victoria Davis

In 2012, the three organizations have partnered to combine Novavax’s vaccine technology, ICGEB’s malaria vaccine research expertise and CPLB manufacturing capability. India’s Department of Biotechnology Vaccine Grand Challenge

RI-002, a specialty plasma-derived, polyclonal intravenous immune globulin, contains naturally occurring polyclonal antibodies (eg. streptococcus pneumoniae, H. influenza type B, CMV, measles, tetanus etc) as well as high